Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P960058/S175

HiResolution Bionic Ear System

Advanced Bionics · Decision date Apr 16, 2026

FDA DECISIONP960058/S175

What did the FDA decide?

FDA records P960058/S175 as a supplement to PMA P960058, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Apr 16, 2026.

FDA approval order statement

approval to insource the electrode wire coating process for the HiRes Ultra and Ultra 3D implants
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Ear, Nose, Throat
Decision date
Apr 16, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P960058/S175
Regulatory pathway
PMA supplement
Product code
MCM
Decision code
OK30
Decision date
Apr 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Implant, cochlear.

Product code
MCM
FDA device class
3

For the original device and its historical approval scope, see PMA P960058. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P960058 · Original PMA

    CLARION MULTI-STRATEGY COCHLEAR IMPLANT

  2. P960058/S171 · Related supplement

    HiResolution Bionic Ear System

  3. P960058/S172 · Related supplement

    HiResolution Bionic Ear System

  4. P960058/S170 · Related supplement

    HiResolution Bionic Ear System

  5. P960058/S175 received

    Application receipt date recorded by FDA.

  6. P960058/S174 · Related supplement

    HiResolution Bionic Ear System Ultra and Ultra 3D Thin PCB

  7. P960058/S173 · Related supplement

    HiResolution Bionic Ear System

  8. P960058/S175 · FDA decision

    30-Day Notice

  9. P960058/S167 · Related supplement

    HiResolution Bionic Ear System

  10. P960058/S177 · Related supplement

    HiResolution Bionic Ear System

  11. P960058/S178 · Related supplement

    CLARION MULTI-STRATEGY COCHLEAR IMPLANT

Timeline entries are records held by MedtechLedger for P960058. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P960058

Product / regulatory recordCompanyPathwayDecision dateSource
Advanced BionicsPMA approvalJun 26, 1997FDA
Advanced BionicsPMA supplementAug 20, 2025FDA
Advanced BionicsPMA supplementOct 14, 2025FDA
Advanced BionicsPMA supplementJan 23, 2026FDA
Advanced BionicsPMA supplementApr 9, 2026FDA
Advanced BionicsPMA supplementApr 16, 2026FDA
Advanced BionicsPMA supplementJul 22, 2026FDA
Advanced BionicsPMA supplementSep 4, 2026FDA
Advanced BionicsPMA supplementSep 18, 2026FDA

Explore the linked device profile

Other records with product code MCM

Product / regulatory recordCompanyPathwayDecision dateSource
Med-El Corp.PMA supplementOct 9, 2026FDA
Cochlear AmericasPMA supplementSep 28, 2026FDA
Cochlear AmericasPMA supplementSep 28, 2026FDA
Cochlear AmericasPMA supplementSep 28, 2026FDA
Cochlear AmericasPMA supplementApr 30, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Advanced Bionics

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
28515 Westinghouse Pl., Valencia, CA, 91355

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records